% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Schmitz:256605,
author = {Schmitz, Matthias and Candelise, Niccolò and Canaslan,
Sezgi and Altmeppen, Hermann C and Matschke, Jakob and
Glatzel, Markus and Younas, Neelam and Zafar, Saima and
Hermann, Peter and Zerr, Inga},
title = {α-{S}ynuclein conformers reveal link to clinical
heterogeneity of α-synucleinopathies.},
journal = {Translational neurodegeneration},
volume = {12},
number = {1},
issn = {2047-9158},
address = {London},
publisher = {Biomed Central},
reportid = {DZNE-2023-00357},
pages = {12},
year = {2023},
note = {CC BY},
abstract = {α-Synucleinopathies, such as Parkinson's disease (PD),
dementia with Lewy bodies (DLB) and multiple system atrophy,
are a class of neurodegenerative diseases exhibiting
intracellular inclusions of misfolded α-synuclein (αSyn),
referred to as Lewy bodies or oligodendroglial cytoplasmic
inclusions (Papp-Lantos bodies). Even though the specific
cellular distribution of aggregated αSyn differs in PD and
DLB patients, both groups show a significant pathological
overlap, raising the discussion of whether PD and DLB are
the same or different diseases. Besides clinical
investigation, we will focus in addition on methodologies,
such as protein seeding assays (real-time quaking-induced
conversion), to discriminate between different types of
α-synucleinopathies. This approach relies on the seeding
conversion properties of misfolded αSyn, supporting the
hypothesis that different conformers of misfolded αSyn may
occur in different types of α-synucleinopathies.
Understanding the pathological processes influencing the
disease progression and phenotype, provoked by different
αSyn conformers, will be important for a personalized
medical treatment in future.},
subtyp = {Review Article},
keywords = {Humans / alpha-Synuclein: genetics / alpha-Synuclein:
metabolism / Synucleinopathies: diagnosis /
Synucleinopathies: genetics / Synucleinopathies: metabolism
/ Parkinson Disease: diagnosis / Parkinson Disease: genetics
/ Parkinson Disease: metabolism / Lewy Bodies: pathology /
Multiple System Atrophy: diagnosis / Multiple System
Atrophy: genetics / Multiple System Atrophy: pathology /
α-synuclein (Other) / Protein strains (Other) / RT-QuIC
(Other) / α-synuclein (Other) / α-synucleinopathies
(Other) / alpha-Synuclein (NLM Chemicals) /
α-synucleinopathies (Other)},
cin = {AG Zerr / Ext UMG Zerr / Clinical Dementia Research
Göttingen},
ddc = {570},
cid = {I:(DE-2719)1440011-1 / I:(DE-2719)5000037 /
I:(DE-2719)1440015},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36915212},
pmc = {pmc:PMC10012698},
doi = {10.1186/s40035-023-00342-4},
url = {https://pub.dzne.de/record/256605},
}